Cargando…
An explainable machine learning ensemble model to predict the risk of ovarian cancer in BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
INTRODUCTION: It has been estimated that 19,880 new cases of ovarian cancer had been diagnosed in 2022. Most epithelial ovarian cancer are sporadic, while in 15%–25% of cases, there is evidence of a familial or inherited component. Approximately 20%–25% of high-grade serous carcinoma cases are cause...
Autores principales: | Comes, Maria Colomba, Arezzo, Francesca, Cormio, Gennaro, Bove, Samantha, Calabrese, Angela, Fanizzi, Annarita, Kardhashi, Anila, La Forgia, Daniele, Legge, Francesco, Romagno, Isabella, Loizzi, Vera, Massafra, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374844/ https://www.ncbi.nlm.nih.gov/pubmed/37519818 http://dx.doi.org/10.3389/fonc.2023.1181792 |
Ejemplares similares
-
A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients
por: Loizzi, Vera, et al.
Publicado: (2022) -
Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan
por: Konnai, Katsuyuki, et al.
Publicado: (2023) -
The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows
por: Loizzi, Vera, et al.
Publicado: (2023) -
Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
por: Conduit, Ciara, et al.
Publicado: (2021) -
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
por: Rebbeck, Timothy R., et al.
Publicado: (2009)